Quantcast
Last updated on April 17, 2014 at 13:47 EDT

Latest Epitope mapping Stories

2013-12-11 16:24:44

BOULDER, Colo. and HUNTINGTON BEACH, Calif., Dec. 11, 2013 /PRNewswire/ -- BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC's 24th Annual Antibody Engineering & Therapeutics Conference and annual meeting of The Antibody Society, being held in Huntington Beach, CA from December 8 - 12, 2013. During the event, BiOptix will be highlighting the BiOptix Innovators Program, a unique and innovative product...

2013-01-07 08:28:19

LELYSTAD, the Netherlands, January 7, 2013 /PRNewswire/ -- Pepscan Therapeutics, a world leader in protein mimicry technologies for raising anti-GPCR antibodies, today announced a multi-target research agreement with an undisclosed US-based antibody discovery company. Under the agreement Pepscan using its CLIPS platform and other protein mimicry technologies will work with the partner in the discovery of novel antibodies. Under the terms of the agreement, Pepscan will receive...

2012-12-03 12:28:01

BOULDER, Colo. and SAN DIEGO, Dec. 3, 2012 /PRNewswire/ -- BiOptix announced today that it will be showcasing the new BiOptix 404pi at IBC's 23(rd) Annual Antibody Engineering and Therapeutics Conference in San Diego. The conference, which runs December 2 - 6, 2012, is one of the preeminent technology symposia in the world for the international antibody development and research community. "The new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based...